When did SINGULAR GENOMICS SYSTEMS IN (OMIC) report earnings last quarter?
SINGULAR GENOMICS SYSTEMS IN (OMIC) last reported earnings on 11/12/2024.
NASDAQ:OMIC • US82933R3084
Past quarterly earnings results for SINGULAR GENOMICS SYSTEMS IN (OMIC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | -6.72 | -8.21 | 18.16% | 27.74% | 406K | 841.5K | -51.75% | -12.12% |
| Q2 2024 | -8.57 | -9.04 | 5.17% | 18.38% | 737K | 408K | 80.64% | 45.94% |
| Q1 2024 | -10.20 | -10.71 | 4.76% | -3.03% | 442K | 401.88K | 9.98% | -48.78% |
| Q4 2023 | -9.60 | -10.51 | 8.62% | -10.34% | 1.081M | 745.957K | 44.91% | 40.39% |
| Q3 2023 | -9.30 | -11.63 | 20.02% | 6.06% | 462K | 1.3M | -64.46% | - |
| Q2 2023 | -10.50 | -11.32 | 7.26% | -2.94% | 505K | 1.174M | -56.98% | - |
| Q1 2023 | -9.90 | -10.83 | 8.61% | -6.45% | 863K | 1.267M | -31.89% | - |
| Q4 2022 | -8.70 | -13.04 | 33.26% | -7.41% | 770K | 774.996K | -0.64% | - |
| Q3 2022 | -9.90 | -12.67 | 21.85% | -32.00% | 76.5K | -100.00% | - | |
| Q2 2022 | -10.20 | -11.75 | 13.19% | 20.93% | 51K | -100.00% | - | |
| Q1 2022 | -9.30 | -10.20 | 8.82% | - | - | - | ||
| Q4 2021 | -8.10 | -9.42 | 14.06% | - | - | - | ||
| Q3 2021 | -7.50 | -7.34 | -2.12% | - | - | - | ||
| Q2 2021 | -12.90 | -6.22 | -107.33% | - | - | - | ||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
SINGULAR GENOMICS SYSTEMS IN (OMIC) last reported earnings on 11/12/2024.
SINGULAR GENOMICS SYSTEMS IN (OMIC) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, SINGULAR GENOMICS SYSTEMS IN (OMIC) has beaten EPS estimates in 4 out of 4 releases.